Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.
2.

Paraneoplastic digital ischemia in clear-cell renal-cell carcinoma: Report of a case and review of the literature.

Kampoli K, Gardeli D, Mouktaroudi M, Fanouriakis A, Lazaris AM, Koumarianou A.

Urologia. 2019 Aug;86(3):156-160. doi: 10.1177/0391560318761289. Epub 2018 Apr 1.

PMID:
31431168
3.

Update on the pathogenesis of central nervous system lupus.

Nikolopoulos D, Fanouriakis A, Boumpas DT.

Curr Opin Rheumatol. 2019 Aug 13. doi: 10.1097/BOR.0000000000000655. [Epub ahead of print]

PMID:
31415031
4.

Response to: 'Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations' by Orsolini et al.

Fanouriakis A, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jul 30. pii: annrheumdis-2019-215944. doi: 10.1136/annrheumdis-2019-215944. [Epub ahead of print] No abstract available.

PMID:
31362992
5.

Response to: 'Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine' by Michaud et al.

Fanouriakis A, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jul 11. pii: annrheumdis-2019-215817. doi: 10.1136/annrheumdis-2019-215817. [Epub ahead of print] No abstract available.

PMID:
31296499
6.

Response to: 'Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus' by Rua-Figueroa and Erausquin.

Fanouriakis A, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jul 3. pii: annrheumdis-2019-215810. doi: 10.1136/annrheumdis-2019-215810. [Epub ahead of print] No abstract available.

PMID:
31270111
7.

Hydroxychloroquine dosing in systemic lupus erythematosus: response to 'Letter in response to the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al' by Costedoat-Chalumeau et al.

Fanouriakis A, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jun 14. pii: annrheumdis-2019-215615. doi: 10.1136/annrheumdis-2019-215615. [Epub ahead of print] No abstract available.

PMID:
31201171
8.

Chloroquine as alternative antimalarial in systemic lupus erythematosus: response to '2019 update of the EULAR recommendations for the management of SLE: don't forget chloroquine' by Figueroa-Parra et al.

Fanouriakis A, Bertsias GK, Boumpas DT.

Ann Rheum Dis. 2019 Jun 8. pii: annrheumdis-2019-215746. doi: 10.1136/annrheumdis-2019-215746. [Epub ahead of print] No abstract available.

PMID:
31177098
9.

Changing paradigms in the treatment of systemic lupus erythematosus.

Fanouriakis A, Bertsias G.

Lupus Sci Med. 2019 Feb 8;6(1):e000310. doi: 10.1136/lupus-2018-000310. eCollection 2019.

10.

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity.

Panousis NI, Bertsias GK, Ongen H, Gergianaki I, Tektonidou MG, Trachana M, Romano-Palumbo L, Bielser D, Howald C, Pamfil C, Fanouriakis A, Kosmara D, Repa A, Sidiropoulos P, Dermitzakis ET, Boumpas DT.

Ann Rheum Dis. 2019 Aug;78(8):1079-1089. doi: 10.1136/annrheumdis-2018-214379. Epub 2019 Jun 5.

11.

Editorial: Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus.

Fanouriakis A, Bertsias G, Govoni M.

Front Med (Lausanne). 2019 Mar 26;6:52. doi: 10.3389/fmed.2019.00052. eCollection 2019. No abstract available.

12.

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT.

Ann Rheum Dis. 2019 Jun;78(6):736-745. doi: 10.1136/annrheumdis-2019-215089. Epub 2019 Mar 29.

PMID:
30926722
13.

Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma.

Spathas N, Economopoulou P, Cheila M, Kotsantis I, Fanouriakis A, Kassara D, Psyrri A.

Front Oncol. 2018 Sep 26;8:409. doi: 10.3389/fonc.2018.00409. eCollection 2018.

14.

2008-2018: a decade of recommendations for systemic lupus erythematosus.

Boumpas DT, Bertsias GK, Fanouriakis A.

Ann Rheum Dis. 2018 Nov;77(11):1547-1548. doi: 10.1136/annrheumdis-2018-214014. No abstract available.

PMID:
30309872
15.

Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up.

Kougkas N, Fanouriakis A, Papalopoulos I, Bertsias G, Avgoustidis N, Repa A, Sidiropoulos P.

Rheumatology (Oxford). 2018 Aug 1;57(8):1494-1495. doi: 10.1093/rheumatology/key077. No abstract available.

PMID:
30060102
16.

Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.

Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S, Staveri C, Klagou A, Tsalapaki C, Pantazi L, Konsta S, Mavragani CP, Dimopoulou D, Ntali S, Katsikas G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A, Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT.

Semin Arthritis Rheum. 2018 Dec;48(3):467-474. doi: 10.1016/j.semarthrit.2018.02.014. Epub 2018 Feb 23.

PMID:
29555348
17.

In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study.

Fanouriakis A, Papalopoulos I, Gergianaki I, Spyrou G, Erden A, Rapsomaniki P, Terizaki M, Avgoustidis N, Repa A, Kougkas N, Bertsias G, Boumpas DT, Sidiropoulos PI.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):806-813. Epub 2018 Feb 28.

PMID:
29533750
18.

Response to: 'Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus' by Papadaki et al' by Wallace.

Papadaki E, Fanouriakis A, Kavroulakis E, Karageorgou D, Sidiropoulos P, Bertsias G, Simos P, Boumpas DT.

Ann Rheum Dis. 2019 Jan;78(1):e6. doi: 10.1136/annrheumdis-2018-212949. Epub 2018 Jan 23. No abstract available.

PMID:
29363512
19.

Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus.

Papadaki E, Fanouriakis A, Kavroulakis E, Karageorgou D, Sidiropoulos P, Bertsias G, Simos P, Boumpas DT.

Ann Rheum Dis. 2018 Mar;77(3):441-448. doi: 10.1136/annrheumdis-2017-212285. Epub 2017 Dec 19.

PMID:
29259047
20.

Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study.

Papalopoulos I, Fanouriakis A, Kougkas N, Flouri I, Sourvinos G, Bertsias G, Repa A, Avgoustidis N, Sidiropoulos P.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):102-109. Epub 2017 Aug 28.

PMID:
28850029

Supplemental Content

Loading ...
Support Center